Static Chart TME Pharma N.V.

Equities

Market Closed - Euronext Paris Other stock markets 11:35:19 2024-05-03 am EDT			5-day change	1st Jan Change
0.2485 ^EUR	+2.05%		-0.20%	+8.04%

Apr. 25	TME Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Apr. 23	TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer	CI

Duration

Period